Undervalued Dividend Growth Stock of the Week: Gilead Sciences (GILD)
This stock offers a 4.5% yield, double-digit dividend growth and the potential that shares are 18% undervalued.
Read MorePosted by Jason Fieber, Dividends And Income | Nov 22, 2020
This stock offers a 4.5% yield, double-digit dividend growth and the potential that shares are 18% undervalued.
Read MorePosted by Jason Fieber, Dividends And Income | Nov 19, 2020
Names include Apple (AAPL), Pfizer (PFE), Wells Fargo (WFC), AbbVie (ABBV), Costco (COST), JPMorgan Chase (JPM) and more.
Read MorePosted by Jason Fieber, Dividends And Income | Nov 15, 2020
This tech giant has shown a unique ability to adapt, time and time again. With a 5%-plus yield, 25 consecutive years of dividend raises, and the potential that shares are 15% undervalued, we’re looking at a rare deal for dividend growth investors.
Read MorePosted by Jason Fieber, Dividends And Income | Nov 8, 2020
This company is a high-margin business with durable competitive advantages. With a 9% yield, more than 50 consecutive years of dividend raises, an on-target payout ratio, and the potential that shares are 32% undervalued, it’s a compelling idea for dividend growth investors looking for yield.
Read MorePosted by Jason Fieber, Dividends And Income | Nov 1, 2020
This stock offers a market-smashing yield near 6%, big dividend growth, and the potential that shares are 30% undervalued. It could be one of the best long-term investments available for dividend growth investors.
Read More